Biocompatible Glycol Chitosan Microgels as Effective Drug Carriers
Sahiner, Mehtap, Aynur S. Yilmaz, Ramesh S. Ayyala, and Nurettin Sahiner. 2023. “Biocompatible Glycol Chitosan Microgels As Effective Drug Carriers”. Gels 9 (5).
Search
Search results
1934 results found
Nontoxic Natural Polymeric Particle Vehicles Derived from Hyaluronic Acid and Mannitol as Mitomycin C Carriers for Bladder Cancer Treatment
Sahiner, Nurettin, Ramesh S. Ayyala, and Selin S. Suner. 2022. “Nontoxic Natural Polymeric Particle Vehicles Derived from Hyaluronic Acid and Mannitol As Mitomycin C Carriers for Bladder Cancer Treatment”. ACS Applied Bio Materials 5 (12): 5554-66.
Fungal Keratitis Treatment Using Drug-Loaded Hyaluronic Acid Microgels
Ayyala, Ramesh S., Selin S. Suner, Venkat R. Bhethanabotla, and Nurettin Sahiner. 2022. “Fungal Keratitis Treatment Using Drug-Loaded Hyaluronic Acid Microgels”. ACS Applied Bio Materials 5 (8): 3806-15.
A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease. Neurology 2001;57:397-404.
Group, The Huntington Study. 2001. “A Randomized, Placebo-Controlled Trial of Coenzyme Q10 and Remacemide in Huntington’s Disease. Neurology 2001;57:397-404.”. Neurology.
A home diary to assess functional status in Parkinson’s disease patients with motor fluctuations and dyskinesia. Journal of Clinical Neuropharmacology 2000;23:75-81.
Hauser, RA, J Friedlander, TA Zesiewicz, CH Adler, LC Seeberger, and . 2000. “A Home Diary to Assess Functional Status in Parkinson’s Disease Patients With Motor Fluctuations and Dyskinesia. Journal of Clinical Neuropharmacology 2000;23:75-81.”. Journal of Clinical Neuropharmacology .
Neural transplantation for the treatment of Huntington's disease. Progress in Brain Research 2000;127:405-11.
Freeman, TB, RA Hauser, PR Sanberg, and S Saporta. 2000. “Neural Transplantation for the Treatment of Huntington’s Disease. Progress in Brain Research 2000;127:405-11.”. Progress in Brain Research .
Current issues in depression in Parkinson’s disease. Am J Geriatr Psych 1999; :110-118.
Zesiewicz, TA, M Gold, G Chari, and RA Hauser. 1999. “Current Issues in Depression in Parkinson’s Disease. Am J Geriatr Psych 1999; :110-118.”. Am J Geriatr Psych.
Management of early Parkinson’s disease. Medical Clinics of North America 1999;83:393-414.
Hauser, RA, and TA Zesiewicz. 1999. “Management of Early Parkinson’s Disease. Medical Clinics of North America 1999;83:393-414.”. Medical Clinics of North America.
Plasma thiamine deficiency associated with Alzheimer’s disease but not Parkinson’s disease. Metabolic Brain Disease 1998;13:43-53.
Gold, M, R Hauser, and MF Chen. 1998. “Plasma Thiamine Deficiency Associated With Alzheimer’s Disease But Not Parkinson’s Disease. Metabolic Brain Disease 1998;13:43-53.”. Metabolic Brain Disease.
Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil. Neurology 1998;51:912-913.
Hauser, RA, AR Malek, and R Rosen. 1998. “Successful Treatment of a Patient With Severe Refractory Myasthenia Gravis Using Mycophenolate Mofetil. Neurology 1998;51:912-913.”. Neurology.